Physician profile
Gregory S Rorick
NPI 1376588640
$2,826.75
in general payments reported to CMS, 2019-2025
19 companies · $1,267 in 2025
The $1,267 reported for 2025 was more than what 84% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $428 · 2021: $44.02 · 2022: $155 · 2023: $178 · 2024: $260 · 2025: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,198.08 | 2024-2025 | |
| Prodigy Surgical Distribution, INC. | $428.45 | 2020 | |
| Horizon Therapeutics Plc | $225.17 | 2019 | |
| Kerecis Limited | $167.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $141.44 | 2019-2022 | |
| Kci USA, INC. | $107.60 | 2023 | V.A.C. Veraflo |
| Depuy Synthes Sales INC. | $88.40 | 2019 | |
| Zimmer Biomet Holdings, INC. | $85.82 | 2019 | |
| Advanced Oxygen Therapy INC. | $84.98 | 2022-2025 | Topical Oxygen Chamber For Extremities |
| Organogenesis INC. | $65.18 | 2022-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $49.05 | 2023 | Nuzyra |
| Alfasigma USA, INC. | $40.36 | 2021-2022 | |
| Stryker Corporation | $35.62 | 2025 | Augment Injectable |
| Mckesson Medical-Surgical, INC. | $25.00 | 2022 | |
| Ani Pharmaceuticals, INC. | $18.32 | 2025 | Purified Cortrophin Gel |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $18.30 | 2025 | Nimbl, Flexitouch Plus |
| Harrow Eye, LLC | $17.28 | 2025 | Iheezo |
| Baudax Bio INC. | $15.66 | 2021 | |
| Merck Sharp & Dohme LLC | $14.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Rorick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.